World’s largest plasma business seeks new blood as CEO departs
Australia’s CSL pledges to ‘deeply examine’ what has gone wrong at former stock market darling
Related reading
The great software stock meltdown
Sell-off may be overdone, but companies need to move faster to respond to AI
First Brands at breaking point as it scrambles to avoid liquidation
The company is relying on a $48mn infusion from automakers to continue operating
What business should be thinking about post-Davos
Ignoring the upside can be as dangerous as discounting the downside
Big Tech groups race to fund unprecedented $660bn AI spending spree
Executives face choice between cutting returns to shareholders, raiding reserves or tapping the markets
The risky bet by AI start-ups
Broader, integrated software platforms for business will win out against those selling specific services
UK biotech keeps selling itself to America
A shortage of late-stage capital pushes the biggest prizes into US hands